AstraZeneca has seen major momentum in oncology in recent years. It got a big showcase at Europe's top cancer conference.
After 100 years, there's finally an effective cancer vaccine. Now comes the push to get them to work in more tumor types.
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. AbbVie on Monday said it would buy ...
Five years after being diagnosed with multiple sclerosis, actor Christina Applegate revealed this week that she had been ...
Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes ...
I felt Christina Applegate’s disappointment as if it were my own — because not long ago, it was,” writes Lindsay Karp.
A new Treasury Department proposal would restrict U.S. investments in Chinese biotechs, but still allows licensing deals.
A multiple sclerosis treatment from Novartis cut by a third the rates of relapses that people with the condition have ...
Bristol Myers Squibb on Friday reported that one patient died after receiving its investigational CAR-T therapy in an early ...
What state officials scrambling to implement Medicaid work requirements shared behind closed doors at the National ...
A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality ...
As a Boston judge heard a challenge to Medicaid work requirements, state Medicaid directors gathered in Maryland to figure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results